| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $731K | -21.4% |
| Cost of Revenue | $682K | -18.1% |
| Gross Profit | $49K | -49.4% |
| R&D Expense | $0 | — |
| SG&A Expense | $17.8M | +446.2% |
| Operating Income | -$17.8M | -461.4% |
| Interest Expense | $0 | -100.0% |
| Net Income | -$21.7M | -32.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17K | -96.8% |
| Accounts Receivable | $94K | -42.3% |
| Inventory | $74K | -52.5% |
| Current Assets | $193K | -88.0% |
| Total Assets | $230K | -86.0% |
| Current Liabilities | $784K | +41.9% |
| Total Liabilities | $1.9M | +47.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$841K | -51.3% |
| Capital Expenditures | $11K | +98.1% |
| Investing Cash Flow | -$11K | -98.1% |
| Financing Cash Flow | $350K | -67.3% |
| Free Cash Flow | -$851K | -51.8% |
| Stockholders' Equity |
| -$4.6M |
| -24.1% |